Skip to main content

Table 3 Major adverse cardiovascular events during clinical follow-up – stratified according to ADMA tertiles and glycemic control

From: Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control

 

ADMA Tertiles

 

Tertile I

Tertile II

Tertile III

p value*

HbA1c ≤6.5% (n = 50)

4 (18.2%)

2 (25.0%)

3 (15.0%)

0.82*

HbA1c >6.5% (n = 220)

6 (8.8%)

15 (18.3%)

25 (35.7%)

<0.001*

  1. MACE: major adverse cardiovascular events, including cardiovascular death, non-fatal myocardial infarction and stroke; *p value by log-rank test.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840